Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Heron Therapeutics (HRTX) Long-Term Debt Issuances (2021 - 2025)

Heron Therapeutics' Long-Term Debt Issuances history spans 3 years, with the latest figure at -$3.4 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to -$3.4 million; the TTM value through Dec 2025 reached -$3.4 million, changed N/A, while the annual FY2025 figure was $105.4 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached -$3.4 million in Q4 2025 per HRTX's latest filing, down from -$19000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of -$19000.0 in Q3 2021 to a low of -$3.4 million in Q4 2025.